Effects of initial use of half-maximal dose rosiglitazone-metformin combination therapy, compared with maximum dose rosiglitazone or metformin, on glucose metabolism in type 2 diabetes mellitus

被引：0
|
作者：
Choe, Charles
Christiansen, Louis
Edelman, Steven
Mudaliar, Sunder
Henry, Robert R.
机构：
来源：
DIABETES | 2006年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A107 / A107
页数：1
相关论文
共 50 条
  • [21] Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus - A randomized controlled trial
    Fonseca, V
    Rosenstock, J
    Patwardhan, R
    Salzman, A
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (13): : 1695 - 1702
  • [22] Effects of metformin, rosiglitazone and insulin on bone metabolism in patients with type 2 diabetes
    Stage, Tore Bjerregaard
    Christensen, Mette-Marie Hougaard
    Jorgensen, Niklas Rye
    Beck-Nielsen, Henning
    Brosen, Kim
    Gram, Jeppe
    Frost, Morten
    BONE, 2018, 112 : 35 - 41
  • [23] Lifetime cost-effectiveness of rosiglitazone/metformin fixed dose combination for the treatment of type 2 diabetes in Portugal
    Taylor, M.
    Shearer, A.
    Bagust, A.
    Vaz, J. P.
    Pereira, J.
    DIABETES, 2006, 55 : A548 - A548
  • [24] Adherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: A retrospective database analysis
    Vanderpoel, DR
    Hussein, MA
    Watson-Heidari, T
    Perry, A
    CLINICAL THERAPEUTICS, 2004, 26 (12) : 2066 - 2075
  • [25] The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus
    Evren Fidan
    H. Onder Ersoz
    Mustafa Yilmaz
    Hulya Yilmaz
    Mustafa Kocak
    Caner Karahan
    Cihangir Erem
    Acta Diabetologica, 2011, 48 : 297 - 302
  • [26] The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus
    Fidan, Evren
    Ersoz, H. Onder
    Yilmaz, Mustafa
    Yilmaz, Hulya
    Kocak, Mustafa
    Karahan, Caner
    Erem, Cihangir
    ACTA DIABETOLOGICA, 2011, 48 (04) : 297 - 302
  • [27] Fewer self-reported gastrointestinal (GI) symptoms with addition of rosiglitazone (RSG) to sub-maximal dose of metformin (MET) compared to maximizing metformin dose in type 2 diabetes mellitus (T2DM) patients
    Dirani, R
    Cobitz, A
    Wooddell, M
    Strow, L
    Waterhouse, B
    DIABETES, 2004, 53 : A122 - A122
  • [28] The effects of rosiglitazone and metformin on the plasma concentrations of resistin in patients with type 2 diabetes mellitus
    Jung, HS
    Youn, BS
    Cho, YM
    Yu, KY
    Park, HJ
    Shin, CS
    Kim, SY
    Lee, HK
    Park, KS
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2005, 54 (03): : 314 - 320
  • [29] Gestational Diabetes Mellitus: A Randomized Study Comparing Insulin Therapy to a Combination of Half-Maximal Dosages of Metformin and Glyburide
    Ardilouze, Jean-Luc
    Menard, Julie
    Hivert, Marie-France
    Perron, Patrice
    Houde, Ghislaine
    Moutquin, Jean-Marie
    Baillargeon, Jean-Patrice
    DIABETES, 2014, 63 : A630 - A630
  • [30] Effects of rosiglitazone in combination with metformin on cardiovascular biomarkers in type 2 diabetes subjects with microalbuminuria
    Bakris, GL
    McMorn, SO
    Weston, WM
    Huang, C
    Heise, MA
    CIRCULATION, 2005, 112 (17) : U917 - U917
12345